(Z)-5-(3,4,5-Tri­meth­oxy­styr­yl)-2,3-di­hydro­thieno[3,4-b][1,4]dioxine

by Liu, Yu-Tao, Chu, Gang
Published 2014

Gefitinib for asymptomatic brain metastasis from advanced non‐small cell lung cancer: Report of a favourable outcome

by Liu, Wen‐Yang, Liu, Yu‐Tao, Yang, Lin, Zhang, Ye, Liu, Peng, Wang, Yan, Hui, Zhou‐Guang
Published 2016

The Molecular Detection and Clinical Significance of ALK Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy

by Zhang, Ning-Ning, Liu, Yu-Tao, Ma, Li, Wang, Lin, Hao, Xue-Zhi, Yuan, Zheng, Lin, Dong-Mei, Li, Dan, Zhou, Yu-Jie, Lin, Hua, Han, Xiao-Hong, Sun, Yan, Shi, Yuankai
Published 2014

Nerve Growth Factor for the Treatment of Spinocerebellar Ataxia Type 3: An Open-label Study

by Tan, Song, Wang, Rui-Hao, Niu, Hui-Xia, Shi, Chang-He, Mao, Cheng-Yuan, Zhang, Rui, Song, Bo, Sun, Shi-Lei, Liu, Xin-Jing, Hou, Hai-Man, Liu, Yu-Tao, Gao, Yuan, Fang, Hui, Kong, Xiang-Dong, Xu, Yu-Ming
Published 2015

Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China

by Liu, Yu-Tao, Hao, Xue-Zhi, Li, Jun-Ling, Hu, Xing-Sheng, Wang, Yan, Wang, Zi-Ping, Wang, Hong-Yu, Wang, Bin, Han, Xiao-Hong, Zhang, Xiang-Ru, Shi, Yuan-Kai
Published 2015